Loading clinical trials...
Loading clinical trials...
The purposes of this study are to evaluate the safety and plasma pharmacokinetics of DE-117 ophthalmic solution (one drop once daily for 7 days) in healthy male adults.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Santen Pharmaceutical Co., Ltd.
NCT07361120 · Fertility, Fertility, Male, and more
NCT07036458 · Healthy Male Adults
NCT06891729 · Healthy Male Adults Participants, Vasectomy
NCT06623812 · Healthy Male Adults Participants
NCT03342963 · Healthy Male Adults
CPC Clinical Trial Hospital, Medipolis Medical Research Institute
Kagoshima
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions